Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Anthrax 2016 NIAID 1K22AI116727-01 Identification of the non-proteolytic mechanism of NLRP1 activation EWALD, SARAH UNIVERSITY OF VIRGINIA VA $162,000
Anthrax 2016 NIAID 5R21AI109465-02 Targeting Heme Transporters for Improved Vaccines against Anthrax MARESSO, ANTHONY BAYLOR COLLEGE OF MEDICINE TX $198,125
Anthrax 2016 NHLBI 5R01HL118390-03 Membrane Serine Protease Activities in Protease Activated Receptor Signaling ANTALIS, TONI UNIVERSITY OF MARYLAND BALTIMORE MD $383,750
Anthrax 2016 NIAID 5R21AI111101-02 Contribution of Certhrax to Virulence of Anthrax-like Bacillus cereus Strain O'BRIEN, ALISON HENRY M. JACKSON FDN FOR THE ADV MIL/MED MD $194,290
Anthrax 2016 NIAID 4R01AI069227-10 Surface Proteins of Bacillus anthracis SCHNEEWIND, OLAF UNIVERSITY OF CHICAGO IL $384,624
Anthrax 2016 NIAID 5R01AI077703-09 Physical Principles of Bacterial Toxin Translocation across Membranes KRANTZ, BRYAN UNIVERSITY OF MARYLAND BALTIMORE MD $383,750
Anthrax 2016 NIAID 4R01AI105172-04 Conjugate Anthrax Vaccine with Dual Virulence Factor Specificity GIRI, LALLAN BIOLOGICS RESOURCES, LLC MD $1,077,395
Anthrax 2016 NIAID 5R01AI110713-03 Analyzing a novel mechanism of action of bacterial cAMP producing toxins BIER, ETHAN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $537,892
Anthrax 2016 NIAID 5R01AI111538-03 Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart RAO, VENIGALLA CATHOLIC UNIVERSITY OF AMERICA DC $636,281
Anthrax 2016 NIAID 5R01AI111535-03 Detection of Biodefense Pathogens Using Phage Diagnostics SCHOFIELD, DAVID GUILD ASSOCIATES, INC. OH $335,037
Anthrax 2016 NIAID 5U19AI109713-03 8682 Broad spectrum Tricyclics GyrB, ParE inhibitors for antibacterial applications BARTIZAL, KENNETH TRIUS THERAPEUTICS, INC. CA $423,312
Anthrax 2016 NIAID 5F30AI110036-03 Assembly of the envelope of Bacillus anthracis vegetative forms LUNDERBERG, JUSTIN UNIVERSITY OF CHICAGO IL $42,910
Anthrax 2016 NIAID 1R21AI122202-01 Bacillus anthracis egress from infected macrophages BLANKE, STEVEN UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $198,250
Anthrax 2016 NIAID 4R01AI099097-04 Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity HUGHES, MOLLY UNIVERSITY OF VIRGINIA VA $395,000
Anthrax 2016 NIAID 5R01AI104586-05 IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors JOHNSON, ALAN HAWAII BIOTECH, INC. HI $1,569,436
Anthrax 2016 NIAID 4R01AI098884-05 Development of Enabling Vector/Antigen Expression Technology for an Orally-Delive SIM, B. PROTEIN POTENTIAL, LLC MD $1,096,039
Anthrax 2016 NIAID 5U19AI117892-02 8838 B Cell Population Dynamics in Affinity Maturation KELSOE, GARNETT DUKE UNIVERSITY NC $549,760
Anthrax 2016 NIAID 5U19AI117892-02 8839 Structures and Interactions of Antibodies Produced by Affinity Maturation HARRISON, STEPHEN CHILDREN'S HOSPITAL CORPORATION MA $305,757
Anthrax 2016 NIAID 2R01AI033537-21 Virulence gene expression by Bacillus anthracis KOEHLER, THERESA UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $346,500
Anthrax 2016 NIAID 5R01AI111495-03 Surface-enhanced Raman Spectroscopy Immunoassay for Detection of Category A Patho PORTER, MARC UNIVERSITY OF UTAH UT $648,901
Anthrax 2016 NIGMS 4SC3GM084809-08 Synthesis of new classes of metal ion chelators for therapeutic applications GOPALAN, ARAVAMUDAN NEW MEXICO STATE UNIVERSITY LAS CRUCES NM $109,500
Anthrax 2016 NIAID 5F31AI110101-03 Functional similarity of PRD-containing virulence regulators in B. anthracis RAYNOR, MALIK UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $29,906
Anthrax 2016 NIAID 5R01AI073843-07 Pathobiology of heme inducible transporters in Gram positive pathogens SKAAR, ERIC VANDERBILT UNIVERSITY TN $20,977
Anthrax 2016 NIAID 5R21AI112725-02 A cyclic di-GMP signaling system of spores of Bacillus anthracis STEWART, GEORGE UNIVERSITY OF MISSOURI-COLUMBIA MO $187,210
Anthrax 2016 NIAID 5R21AI117425-02 Microparticles for Directing Immune Cell Trafficking POPOV, SERGUEI GEORGE MASON UNIVERSITY VA $228,000
Anthrax 2016 NIAID 5R21AI118228-02 Targeted-delivery of small interference RNA against anthrax ZENG, MINGTAO TEXAS TECH UNIVERSITY HEALTH SCIS CENTER TX $229,500
Anthrax 2016 NIAID 1R21AI124063-01 Manipulation of host complement by Clostridium difficile spores - an immune evasion strategy. XU, YI TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR TX $185,625
Anthrax 2016 NIAID 1R21AI124020-01 Molecular analyses of toxin nanopore structural dynamics KRANTZ, BRYAN UNIVERSITY OF MARYLAND BALTIMORE MD $244,500
Anthrax 2016 NIAID 5R21AI105664-02 Bacillus-containing vacuole-mediated interactions of Bacillus anthracis with macrophages BLANKE, STEVEN UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $237,900
Anthrax 2016 NIGMS 5R01GM117617-02 Spatio-temporally explicit estimation of R0 for pathogens with environmentally-mediated transmission BLACKBURN, JASON UNIVERSITY OF FLORIDA FL $361,761
Anthrax 2016 NIAID 5U19AI062629-13 7600 Toxin-Mediated Suppression of Human PBMC Responses During Bacteremia BALLARD, JIMMY UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $481,245
Anthrax 2016 NIAID 5U19AI062629-13 7601 Mechanisms by which B. anthracis Spores Escape the Lung METCALF, JORDAN UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $457,950
Anthrax 2016 NIAID 5U19AI062629-13 7602 Anti-Peptidoglycan Antibodies and Complement in Anthrax Pathogenesis COGGESHALL, KENNETH OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $384,286
Anthrax 2016 NIAID 5U19AI062629-13 7603 Humoral Mechanisms of Protection from Bacillus anthracis Sepsis FARRIS, A OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $591,209
Anthrax 2016 NIAID 5U19AI062629-13 7604 Administrative Core COGGESHALL, KENNETH OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $141,419
Anthrax 2016 NIAID 5U19AI062629-13 7605 Pilot Project Program BALLARD, JIMMY UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $147,802
Anthrax 2016 NIAID 5U19AI062629-13 7606 Animal Model Core LUPU, FLOREA OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $472,967
Anthrax 2016 NIAID 5U19AI062629-13 7607 Flow Cytometry Core THOMPSON, LINDA OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $73,901
Anthrax 2016 NIAID 5U19AI062629-13 7608 Human Antibody Core SMITH, KENNETH OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $147,802
Anthrax 2016 NIAID 5R33AI102223-05 Host Vascular Mechanism for Therapeutic Protection against Select Pathogens CHAN, JOANNE HAMPTON UNIVERSITY VA $444,000
Anthrax 2016 NIAID 5R01AI111466-03 Enhanced Shelf-life Nanovaccine Formulation for Immunity to Biodefense Pathogens NARASIMHAN, BALAJI IOWA STATE UNIVERSITY IA $346,838
Anthrax 2016 NIAID 3R21AI118228-02S1 Targeted-delivery of small interference RNA against anthrax (1 R21 AI118228-01A1) ZENG, MINGTAO TEXAS TECH UNIVERSITY HEALTH SCIS CENTER TX $56,792
Anthrax 2016 NCI 261200800001E-96-0-3 DCTD Computer Support HEIMBROOK, DAVID LEIDOS BIOMEDICAL RESEARCH, INC. MD $3,704,220
Anthrax 2016 NIAID 272201100022I-6-27200004-8 Task 4: The Interventional Agent Development Services program MIRSALIS, JON SRI INTERNATIONAL CA $306,179
Anthrax 2016 NIAID 272201400040C-2-0-1 DEVELOPMENT OF ANTHRAX VACCINE FORMULATIONS TROYER, JOHN PHARMATHENE, INC. MD $3,818,071
Anthrax 2016 NIAID 1R01AI127658-01 Novel vita-vaccine formula combines safety of dead and efficacy of live vaccines BLANDER, JULIE MAGARIAN ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $421,942
Anthrax 2016 NIAID 6R01AI073843-08 Pathobiology of heme inducible transporters in Gram positive pathogens SKAAR, ERIC VANDERBILT UNIVERSITY MEDICAL CENTER TN $373,004
Anthrax 2016 NIAID 272201400038C-3-0-1 DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N LEMIALE, LAURENCE EMERGENT PRODUCT DEVELOPMENT GAITHERSBUR MD $4,181,877
Anthrax 2016 NIAID 3U19AI062629-12S1 7413 Anti-Peptidoglycan Antibodies and Complement in Anthrax Pathogenesis COGGESHALL, KENNETH OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $225,590
Anthrax 2016 NIAID 272201200033C-8-0-1 Technologies to Advance Next Generation Anthrax Vaccines SQUIRES, CHUCK PFENEX, INC. CA $1,025,879
Anthrax 2016 NIAID 272201000036C-8-0-1 Development of Technologies to Facilitate the use and Response of Vaccines GURWITH, MARC PAXVAX, INC. CA $593,314
Anthrax 2016 NIAID 272201200026C-9-0-2 STRUCTURAL GENOMICS CENTERS FOR INFECTIOUS DISEASES ANDERSON, WAYNE NORTHWESTERN UNIVERSITY AT CHICAGO IL $891,026
Anthrax 2016 NIAID 272201100028C-23-0-3 DEVELOPMENT OF NOVEL TETRACYCLINE COUNTERMEASURES FOR RESPIRATORY DISEASES RADCLIFF, ANNE CUBRC, INC. NY $3,184,516
Anthrax 2016 NIAID 272201000040I-2-27200010-1 TASK A74: Small Animal Screening Models to Assess New and Innovative Drug Candidates Against Bacillus Anthracis BEASLEY, DAVID UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $701,677
Anthrax 2016 NIAID 272201300029C-5-0-1 Development of an Adjuvant with Vaccines for Anthrax, and West Nile Virus (WNV) KOONTZ, CASEY SCIENCE APPLICATIONS INTE VA $1,933,277
Anthrax 2016 NIAID 272201000003I-9-27200003-1 Task C01: Efficacy Testing of Therapeutics Against Inhalational Anthrax in NHPs BRUCE, MARY BATTELLE CENTERS/PUB HLTH RES & EVALUATN OH $11,417
Anthrax 2016 NIAID 272201600002C-0-0-1 Advanced Development of Multiplex Diagnostic Platforms for Infectious Diseases PHILLIPS, CYNTHIA BIOFIRE DIAGNOSTICS, INC. UT $2,995,692
Anthrax 2016 NIAID 272201200034C-7-0-1 Technologies to Advance Next Generation Anthrax Vaccines YUSIBOV, VIDADI CENTER FOR EXPERMENTAL SOFTWARE ENGR MD MD $762,432
Anthrax 2016 NIAID 1ZIAAI000984-10 Influenza and Emerging Infectious Diseases DAVEY, RICHARD NIH $2,420,158
Anthrax 2016 NIAID 272201500012C-1-0-1 Optimizing Lead Therapeutic Compounds Against Infectious Diseases THALE, JARVIS CRESTONE, INC. CO $1,507,181
Anthrax 2016 NCI 1ZIABC009369-26 Studies of Receptor Interactions and Effects of Alarmins OPPENHEIM, JOOST NIH $1,219,341
Anthrax 2016 NIAID 272201100012I-0-27200010-1 Task A25: In vitro screening for antibacterial activity against biodefense and emerging infectious disease pathogens RICHTER, STEFAN SOUTHERN RESEARCH INSTITUTE AL $83,400
Anthrax 2016 NIAID 1ZIAAI000929-14 Vaccines and Therapeutics for Anthrax LEPPLA, STEPHEN NIH $754,329
Anthrax 2016 NIAID 1ZIAAI001030-09 Molecular Genetics and Pathogenesis of Anthrax LEPPLA, STEPHEN NIH $431,045
Anthrax 2016 NIAID 1ZIAAI001031-09 Structure and Function of Virulence Factors of Bacillus anthracis LEPPLA, STEPHEN NIH $538,806
Anthrax 2016 NIAID 1ZIAAI001032-09 Pathophysiological Actions of Anthrax Virulence Determinants LEPPLA, STEPHEN NIH $431,045
Anthrax 2016 NIAID 1ZIAAI000936-13 Pathogenesis, Treatment and Prevention of Emerging Infectious Diseases LANE, CLIFFORD NIH $2,688,099
Anthrax 2016 NIDDK 1ZIADK059701-43 Reactions And Immunochemistry Of Carbohydrates KOVAC, PAVOL NIH $799,147


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer